Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2018 / Cilt: 52 - Sayı: 3

Discriminating Performance of Early Uterine and Cervical Artery Pulsatility and Resistivity In Pre-Invasive Cervical Lesions

Pages
204–209
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, RI of UA and CA differed with regard to the presence of HPV infection, whereas CA-RI differed in high-riskHPV cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of the present study was to investigate the diagnostic effectiveness of uterine and cervical vascularity aloneor in combination with human papillomavirus (HPV) DNA testing and with cytology.Methods: Data were prospectively collected from 129 patients in an outpatient clinic of a secondary setting.
📊
Key Findings & Data:Diagnostic efficiency of alone and joint screening of the threeindices for discriminating cervical intraepithelial neoplasia (CIN-I) or above from below was assessed.Results: UA-RI and CA-RI were significantly lower in the HPV (+) group than in the controls (p=0.02 and p=0.03, respectively).
💡
Conclusion & Impact:In addition, RI of UA and CA differed with regard to the presence of HPV infection, whereas CA-RI differed in high-riskHPV cases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: The aim of the present study was to investigate the diagnostic effectiveness of uterine and cervical vascularity aloneor in combination with human papillomavirus (HPV) DNA testing and with cytology.Methods: Data were prospectively collected from 129 patients in an outpatient clinic of a secondary setting. Routine liquid-basedcervical cytology and HPV-DNA testing were obtained. An abnormal result of any of these high-risk types was viewed as positive.Pulsatility (PI) and resistance (RI) indices of uterine (UA) and cervical (CA) arteries were assessed by Doppler sonography. Pathologicaldiagnosis was considered as the gold standard for assessment. Diagnostic efficiency of alone and joint screening of the threeindices for discriminating cervical intraepithelial neoplasia (CIN-I) or above from below was assessed.Results: UA-RI and CA-RI were significantly lower in the HPV (+) group than in the controls (p=0.02 and p=0.03, respectively). Insubsequent sub-analysis among patients with positive HPV-DNA, UA-PI was significantly higher in the HPV-16 (+) group than in theHPV-18 (+) group (p=0.04). High-risk HPV (Hr-HPV) testing had the highest sensitivity compared with Doppler and cytology (76.5%,64.7%, and 58.5%, respectively). Combining CA-RI with cytology or Hr-HPV significantly reduced the sensitivity (23.5% and 29.4,respectively) but improved the specificity from 54.4% to 69.8% and 40.9% to 70.7%, respectively. Combining UA-PI with Hr-HPVslightly increased the positive predictivity when compared with testing Hr-HPV alone (36.1% vs. 33.3%).Conclusion: The potential of the Doppler indices of UA and CA was doubtful in discriminating CIN-I or above lesions in the earlyperiod. In addition, RI of UA and CA differed with regard to the presence of HPV infection, whereas CA-RI differed in high-riskHPV cases.

🔖

Cite This Article

DOĞAN, O., PULATOGLU, C., BAŞBUĞ, A., KAYA, A. E., YASSA, M. (2018). Discriminating Performance of Early Uterine and Cervical Artery Pulsatility and Resistivity In Pre-Invasive Cervical Lesions. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 52 - Sayı: 3, 204–209. https://ajindex.com/articles/364022

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin 2017;67:7–30.
  2. Vaccarella S, Franceschi S, Engholm G, Lönnberg S, Khan S, Bray F. 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence. Br J Cancer 2014;111:965–9.
  3. Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, et al; International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet2014;383:524–32. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342–50.
  4. Pileggi C, Flotta D, Bianco A, Nobile CG, Pavia M. Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials. Int J Cancer 2014;135:166–77.
  5. Del Mistro A, Frayle H, Ferro A, Callegaro S, Del Sole A, Stomeo A, et al; Veneto HPV-screening Working Group. Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women. J Med Screen 2014;21:30–7.
  6. Vallikad E, Siddartha PT, Kulkarni KA, Firtion C, Keswarpu P, Vajinepalli P, et al. Intra and Inter-Observer Variability of Transformation Zone Assessment in Colposcopy: A Qualitative and Quantitative Study. J Clin Diagn Res 2017;11:XC04X–6. Alcázar JL. Transvaginal Color Doppler in the Assessment of Cervical Carcinoma. Cancer Therapy 2005;3:139–46.
  7. Jurado M, Galván R, Martinez-Monge R, Mazaira J, Alcazar JL. Neoangiogenesis in early cervical cancer: correlation between color Doppler findings and risk factors. A prospective observational study. World J Surg Oncol 2008;6:126. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al; 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17:S1–27. Testa AC, Di Legge A, De Blasis I, Moruzzi MC, Bonatti M, Collarino A, et al. Imaging techniques for the evaluation of cervical cancer. Best Pract Res Clin Obstet Gynaecol 2014;28:741–68.
  8. Fischerova D, Cibula D, Stenhova H, Vond